This is your one stop shop for updates on CTTI projects, developments in the clinical trials enterprise and other relevant news. To read the full-length entry, or to share a specific blog post, click on the title of the article of interest.
Apply Filter View All
Are you curious about what the FDA is doing to integrate patient engagement throughout the agency? Wondering how CTTI is collaborating on some of these efforts? Learn about a variety of initiatives during a CTTI-hosted webinar Thurs., Nov. 21, from 12:00 - 1:00 p.m. ET.
Confirmed speakers for “Patient Engagement in Action: Insights from Patients & the FDA” include:
A recording is now available of the public webinar held on Thurs., Oct. 17, to launch CTTI’s new recommendations for using real-world data (RWD) to plan trial eligibility criteria and recruit participants. The webinar was led by Sudha Raman of Duke University, and Jack Sheehan of Janssen Scientific Affairs.
CTTI conducted research and collaborated with stakeholders across the clinical trials ecosystem to develop these recommendations and resources, including three in-depth case...
Why are turnover rates so high for site investigators? What can be done to strengthen the investigator community? CTTI’s exploration of this question and resulting recommendations were published this week in the peer-reviewed journal Contemporary Clinical Trials Communications .
CTTI’s work on improving the Investigator Community aimed to...
CTTI today released new recommendations, resources, and case studies for using electronic medical records (EHRs) and claims data to plan trial eligibility criteria and recruit participants. The work fills an important gap across the clinical trials ecosystem, where the potential benefits of real-world data (RWD) have been widely acknowledged, but few resources have emerged to lead sponsors and others through the process of formally integrating RWD into their trial designs.
“We are excited to unveil this...
CTTI will host a public webinar on Thurs., Oct. 17, to announce new recommendations, resources, and case studies on how to use real-world data (RWD) to evaluate trial eligibility criteria and recruit potential participants.
“Until now, there have been few resources available to help sponsors and others optimally integrate the use of RWD into their trial design,” said CTTI Executive Director Pamela Tenaerts. “The work we are launching today fills that gap—our new...
